Fig. 3From: A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitorMedian plasma GSK3008348 concentration-time plotBack to article page